From patent updates to grants, here are five developments in orthopedic biologics over the last 30 days:
Biologics
Ortho Regenerative Technologies received a $500,000 grant from Axelys to develop its Ortho-M meniscus repair product.
Several orthopedic regenerative products have been released or FDA approved in 2022.
Bonesupport's Cerament G, an injectable combination antibiotic bone graft substitute, earned FDA market authorization.
Regenerative medicine in spine and orthopedics is gaining momentum, and many surgeons expect further development and research for the field in the near future.
Advertisement
Kuros Biosciences launched the MagnetOs Easypack Putty in the U.S.
Ortho Regenerative Technologies received a patent related to its Ortho-R soft tissue repair platform.
Xtant Medical named Scott Neils as CFO starting June 1.
A healthcare analytics company broke into the medtech market, acquiring Pur Biologics.
From approvals to acquisitions, here are eight developments in regenerative medicine to know since March 1.